Login / Signup

A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing.

Sarah GlewisMarliese AlexanderMuhammad N H KhabibAnnabelle BrennanSmaro LazarakisJennifer MartinJeanne TieSenthil LingaratnamMichael Michael
Published in: British journal of cancer (2022)
The study is registered with PROSPERO, registration number CRD42020223768.
Keyphrases
  • healthcare
  • palliative care
  • oxidative stress
  • quality improvement
  • chronic pain
  • affordable care act